Get started
Author

Sandrine Martin

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
2006 · Jean-Marie Brusq, Nicolas Ancellin, et al. · Journal of Lipid Research · 348
PDF
Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
2011 · Chun-wa Chung, Hervé Coste, et al. · Journal of Medicinal Chemistry · 338
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
2012 · Alexis Broisat, Sophie Hernot, et al. · Circulation Research · 206
PDF
From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
2012 · Olivier Mirguet, Yann Lamotte, et al. · Bioorganic & Medicinal Chemistry Letters · 115
Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models
2009 · Marc Issandou, Anne Bouillot, et al. · European Journal of Pharmacology · 50
Identification of predictive factors of response to the BH3‐mimetic molecule ABT‐737: An ex vivo experiment in human serous ovarian carcinoma
2014 · Stéphanie Lheureux, Monique N'Diaye, et al. · International Journal of Cancer · 43
A Safe Bacterial Microsyringe for In Vivo Antigen Delivery and Immunotherapy
2013 · Audrey Le Gouëllec, Xavier Chauchet, et al. · Molecular Therapy · 27
PDF
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
2020 · C. Lenck, N. Chopin, et al. · Gynecologic Oncology · 21
A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant therapy in patients with FIGO stage IIIc/IV ovarian, tubal, or peritoneal adenocarcinoma, initially unresectable.
2014 · Roman Rouzier, Philippe Morice, et al. · Journal of Clinical Oncology · 7
Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: An ex vivo experiment in human serous ovarian carcinoma.
2014 · Stephanie Lheureux, Monique N'Diaye, et al. · Journal of Clinical Oncology · 5
Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids
2025 · Lucie Thorel, Nicolas Elie, et al. · Laboratory Investigation · 4
PDF
CHRONO: A randomized phase II trial of the chronology of surgery after neoadjuvant chemotherapy for ovarian cancer.
2026 · Gwenael Ferron, Pierre-Francois Dupre, et al. · Journal of Clinical Oncology · 3
Correlation of baseline clinical characteristics and laparoscopic extent of carcinomatosis of women with initially unresectable ovarian, tubal or peritoneal adenocarcinoma, in ANTHALYA study: A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant.
2015 · Roman Rouzier, Sebastien Gouy, et al. · Journal of Clinical Oncology · 1
Abstract 6112: Automated scoring to assess RAD51-mediated homologous recombination in patient-derived tumor organoids of ovarian cancers
2023 · Lucie Thorel, Pierre-Marie Morice, et al. · Cancer Research
EP1225 How the conformity of surgical practice with the national guidelines improved the quality of management of ovarian granulosa cell tumors (GCT)? A TMRG and GINECO group study
2019 · C. Lenck, N. Chopin, et al. · International Journal of Gynecological Cancer
The emergence of an insulin-responsive glucose transport system during adipocyte differentiation correlates with the segregation of GLUT4 from recycling endosomes
2001 · Sandrine Martin, Handunge Kumudu Irani Perera, et al. · Molecular Biology of the Cell
Overexpression of Glut4 in adipocytes of transgenic mice saturates sorting.
1996 · KL Houseknecht, Sandrine Martin, et al. · Diabetes
Works count: 17
Citation count: 1,168
H-index: 8
I10-index: 8
Year
Topic
Type